MWM
TMO icon

Mission Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Mission Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.34M Buy
4,755
+58
+1% +$31.5K 0.05% 195
2025
Q4 		$2.72M Sell
4,697
-25
-0.5% -$14.1K 0.05% 182
2025
Q3 		$2.29M Sell
4,722
-97
-2% -$45.1K 0.05% 202
2025
Q2 		$1.95M Sell
4,819
-232
-5% -$97K 0.04% 212
2025
Q1 		$2.51M Buy
5,051
+668
+15% +$362K 0.06% 168
2024
Q4 		$2.28M Sell
4,383
-313
-7% -$172K 0.05% 170
2024
Q3 		$2.9M Buy
4,696
+183
+4% +$108K 0.07% 142
2024
Q2 		$2.5M Buy
4,513
+187
+4% +$107K 0.07% 147
2024
Q1 		$2.51M Buy
4,326
+342
+9% +$192K 0.07% 157
2023
Q4 		$2.11M Sell
3,984
-172
-4% -$83.3K 0.07% 143
2023
Q3 		$2.1M Buy
4,156
+1,026
+33% +$547K 0.08% 127
2023
Q2 		$1.63M Buy
3,130
+235
+8% +$127K 0.06% 153
2023
Q1 		$1.67M Sell
2,895
-50
-2% -$28.2K 0.07% 150
2022
Q4 		$1.62M Buy
2,945
+425
+17% +$225K 0.08% 139
2022
Q3 		$1.28M Buy
2,520
+225
+10% +$126K 0.07% 153
2022
Q2 		$1.25M Buy
2,295
+5
+0.2% +$2.75K 0.07% 160
2022
Q1 		$1.35M Sell
2,290
-24
-1% -$13.8K 0.06% 156
2021
Q4 		$1.54M Sell
2,314
-11
-0.5% -$6.87K 0.07% 138
2021
Q3 		$1.33M Buy
2,325
+44
+2% +$24.1K 0.07% 145
2021
Q2 		$1.15M Sell
2,281
-145
-6% -$68.4K 0.06% 155
2021
Q1 		$1.11M Buy
2,426
+80
+3% +$38.2K 0.06% 141
2020
Q4 		$1.09M Buy
2,346
+146
+7% +$68.5K 0.07% 137
2020
Q3 		$971K Buy
2,200
+76
+4% +$31.4K 0.07% 129
2020
Q2 		$770K Sell
2,124
-25
-1% -$8.38K 0.07% 140
2020
Q1 		$609K Buy
2,149
+203
+10% +$64K 0.07% 135
2019
Q4 		$632K Sell
1,946
-52
-3% -$15.8K 0.06% 155
2019
Q3 		$582K Buy
1,998
+7
+0.4% +$2K 0.06% 155
2019
Q2 		$585K Sell
1,991
-107
-5% -$29.5K 0.07% 152
2019
Q1 		$574K Buy
2,098
+305
+17% +$75.9K 0.07% 150
2018
Q4 		$401K Buy
1,793
+61
+4% +$14.3K 0.05% 171
2018
Q3 		$423K Buy
+1,732
New +$398K 0.06% 172

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Mission Wealth Management's TMO Position: Q1 2026 in Review

Mission Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 1.2% in Q1 2026, buying an estimated $31.5K and bringing the position to 4,755 shares worth $2.34M. The position accounts for 0.05% of the portfolio, ranked #195.

Mission Wealth Management first reported a position in TMO in Q3 2018 and has held it in 31 quarters since. The position peaked at $2.9M in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Mission Wealth Management held 4,755 shares of Thermo Fisher Scientific worth $2.34M as of Q1 2026.
  • Mission Wealth Management bought 58 Thermo Fisher Scientific shares in Q1 2026, an estimated $31.5K.
  • Thermo Fisher Scientific made up 0.05% of Mission Wealth Management's portfolio in Q1 2026, its #195 holding.
  • Mission Wealth Management first reported a position in Thermo Fisher Scientific in Q3 2018 and has held it in 31 quarters since.
  • Mission Wealth Management's Thermo Fisher Scientific position peaked at $2.9M in Q3 2024.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Mission Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.